Carmenta Bioscience

About:

Carmenta Bioscience is a technology company focused on improving maternal and fetal health.

Top Investors: Life Science Angels, StartX (Stanford-StartX Fund), Nathaniel David, Camille Samuels

Description:

Carmenta Bioscience is a privately held medical technology company dedicated to improving maternal and fetal health. Spun-out of Stanford University School of Medicine in 2012, Carmenta Bioscience is currently developing a highly accurate, serum-based diagnostic test for preeclampsia.

Total Funding Amount:

$2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2012-04-09

Founders:

Atul Butte, Bruce Ling, Matthew Cooper

Number of Employees:

1-10

Last Funding Date:

2014-01-01

IPO Status:

Private

Industries: